Loading...
*  Leptin to Treat Lipodystrophy - Full Text View - ClinicalTrials.gov
Lipoatrophic Diabetes. Diabetes Mellitus. Hypertriglyceridemia. NASH. Lipodystrophy. Leptin. Diabetes. Additional relevant MeSH ... Lipoatrophic diabetes is a syndrome characterized by insulin resistance in association with a paucity of adipose tissue. ... For the last fourteen years, we have been studying the extent to which leptin deficiency causes diabetes in lipoatrophic ... National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). ClinicalTrials.gov Identifier:. NCT00025883 History ...
https://clinicaltrials.gov/ct2/show/NCT00025883?term=%22mandibuloacral+dysplasia%22+%5BDISEASE%5D+OR+NCT00025883+%5BID-NUMBER%5D+OR+NCT00715546+%5BID-NUMBER%5D+OR+NCT00677313+%5BID-NUMBER%5D+OR+NCT00457938+%5BID-NUMBER%5D&rank=4
*  Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus. ...
Type II Diabetes. Diabetes Mellitus, Lipoatrophic. Dyslipidemia. Drug Therapy. Additional relevant MeSH terms: Layout table for ... Diabetes Mellitus Drug: Pioglitazone and Metformin Drug: Glibenclamide and Metformin Phase 4 ... Diabetes Mellitus. Glucose Metabolism Disorders. Metabolic Diseases. Endocrine System Diseases. Metformin. Pioglitazone. ... Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus ...
https://www.clinicaltrials.gov/ct2/show/NCT00770835?term=stem+cell+diabetes&
*  Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus - Full Text View - ClinicalTrials.gov
Diabetes Mellitus, Lipoatrophic. Dyslipidemia. Drug Therapy. Additional relevant MeSH terms: Diabetes Mellitus. Glucose ... Type 2 diabetes mellitus is a complex metabolic disorder characterized by abnormal insulin secretion and glucose homeostasis, ... The aim of this study is to evaluate SYR-472 in subjects with type 2 diabetes mellitus who have not previously achieved ... Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus. This study has been completed. ...
https://clinicaltrials.gov/ct2/show/study/NCT00760344?show_locs=Y
*  Acanthosis Nigricans: Background, Pathophysiology, Etiology
Acanthosis nigricans among women with gestational diabetes mellitus and risk of adverse pregnancy outcomes. Diabetes Care. 2008 ... The type B syndrome generally occurs in women who have uncontrolled diabetes mellitus, ovarian hyperandrogenism, or an ... Acanthosis Nigricans in Children With Type 2 Diabetes * Five Types of Diabetes: Will New Classification Make Management Easier? ... the Cherokee Diabetes Study. Diabetes Care. 2002 Jun. 25(6):1009-14. [Medline]. ...
https://emedicine.medscape.com/article/1102488-overview
*  Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2...
Type II Diabetes. Diabetes Mellitus, Lipoatrophic. Dyslipidemia. Drug Therapy. Atherosclerosis. Additional relevant MeSH terms ... Diabetes Mellitus. Diabetes Mellitus, Type 2. Glucose Metabolism Disorders. Metabolic Diseases. Endocrine System Diseases. ... Had type I diabetes mellitus.. *Had participated in another investigational study, or participated in an investigational study ... Had a diagnosis of type 2 diabetes mellitus. *Have received appropriate counseling on lifestyle modification for type 2 ...
https://clinicaltrials.gov/ct2/show/study/NCT00225277?show_locs=Y
*  Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus. - Full Text...
Diabetes Mellitus, Lipoatrophic. Dyslipidemia. Drug Therapy. Additional relevant MeSH terms: Diabetes Mellitus. Diabetes ... Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.. The safety ... Type 2 Diabetes according to the American Diabetes Association Criteria.. *Treatment with Glimepiride monotherapy (1-3 mg per ... Genetics Home Reference related topics: Type 2 diabetes Drug Information available for: Glimepiride Pioglitazone Pioglitazone ...
https://clinicaltrials.gov/ct2/show/NCT00770952
*  Pharmacokinetics, Pharmacodynamics and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus
Diabetes Mellitus, Lipoatrophic. A type of diabetes mellitus that is characterized by severe INSULIN RESISTANCE and ... Diabetes Mellitus, Type 1. A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the ... Diabetes Mellitus, Type 2. A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is ... A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and ...
https://www.bioportfolio.com/resources/trial/73837/Pharmacokinetics-Pharmacodynamics-and-Safety-of-Alogliptin-in-Children-Adolescents-and-Adults-With.html
*  Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus. - Full Text View -...
Diabetes Mellitus, Lipoatrophic. Dyslipidemia. Drug Therapy. Additional relevant MeSH terms: Diabetes Mellitus. Diabetes ... Must be diagnosed with type 2 diabetes mellitus using American Diabetes Association diagnostic criteria, and on a stable dose ... Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus. (ORIGAMI). The ... This study was designed to evaluate the glycemic control and safety of TAK-559 in patients with type 2 diabetes mellitus taking ...
https://clinicaltrials.gov/ct2/show/NCT00759720
*  Frequency of alcohol consumption and risk of type 2 diabetes mellitus: A nationwide cohort study.
Alcohol consumption correlates with type 2 diabetes through its effects on insulin resistance, changes in alcohol metabolite ... Diabetes Mellitus, Lipoatrophic. A type of diabetes mellitus that is characterized by severe INSULIN RESISTANCE and ... Both type 1 diabetes (T1D) and type 2 diabetes (T2D) are classified as forms of diabetes mellitus (DM) and commonly considered ... Diabetes Mellitus, Type 1. A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the ...
https://www.bioportfolio.com/resources/pmarticle/2215721/Frequency-of-alcohol-consumption-and-risk-of-type-2-diabetes-mellitus-A.html
*  Does Pioglitazone Increase the Production of Prostacyclin (PGI2) and/or 15-EPI-Lipoxin A4 in Humans With Diabetes Mellitus Type...
Patients with type 2 diabetes mellitus are at high risk of developing ... ... clinicaltrials.gov Type-2 diabetes mellitus is a public health concern. ... Diabetes Mellitus, Lipoatrophic. A type of diabetes mellitus that is characterized by severe INSULIN RESISTANCE and ... diabetes mellitus affects more than 180 million people worldwide. Type 2 diabetes mellitus accounts for 80-95% of diabetes ...
https://www.bioportfolio.com/resources/trial/69400/Does-Pioglitazone-Increase-the-Production-of-Prostacyclin-PGI2-and-or-15-EPI.html
*  Blood-retinal Barrier Imaging and Neuropsychiatric Sequela in Type 2 Diabetes Mellitus
... clinicaltrials.gov In Type 2 Diabetes mellitus patients we will: 1. quantify vasculopathy and blood-retinal barrier (BRB) ... Diabetes Mellitus, Lipoatrophic. A type of diabetes mellitus that is characterized by severe INSULIN RESISTANCE and ... Diabetes Mellitus, Type 1. A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the ... Diabetes Mellitus, Type 2. A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is ...
https://www.bioportfolio.com/resources/trial/65836/Blood-retinal-Barrier-Imaging-and-Neuropsychiatric-Sequela-in-Type-2-Diabetes-Mellitus.html
*  Peripheral Matters: High Rate of Unplanned Admissions and Predictors Identified in Critical Limb Ischemia - American College...
Keywords: Cardiology Interventions, ACC Publications, Diabetes Mellitus, Lipoatrophic, Comorbidity, Patient Discharge, Patient ... septicemia and diabetes-related non-vascular causes. ... Succeed in Managing Cardiovascular Risk in Diabetes Initiative ...
http://www.acc.org/latest-in-cardiology/articles/2017/04/17/11/33/peripheralmatters
*  Generalized Lipodystrophy: Practice Essentials, Overview, Lipodystrophy, Lipoatrophy, and Lipoatrophic Diabetes
The term lipoatrophic diabetes refers to diabetes mellitus in association with lipoatrophy. Lipodystrophy encompasses ... Lipoatrophic diabetes mellitus treated by continuous subcutaneous insulin infusion. Diabetes Metab. 1998 Dec. 24(6):544-6. [ ... Pediatric Type 2 Diabetes Mellitus * Quiz: How Well Do You Know the Risk Factors and Treatment Indications for Type 2 Diabetes ... Molecular scanning of beta-3-adrenergic receptor gene in total congenital lipoatrophic diabetes mellitus. J Clin Endocrinol ...
https://emedicine.medscape.com/article/128355-overview
*  Lipoatrophic diabetes - Wikipedia
Lipoatrophic diabetes is a type of diabetes mellitus presenting with severe lipodystrophy in addition to the traditional signs ... "Lipoatrophic diabetes mellitus treated by continuous subcutaneous insulin infusion". Diabetes Metab. 24 (6): 544-6. PMID ... Morse A, Whitaker M (2000). "Successful pregnancy in a woman with lipoatrophic diabetes mellitus. A case report". J Reprod Med ... "Lipoatrophic diabetes in an elderly woman: clinical course and serum adipocytokine concentrations". Endocr J. 51 (3): 279-86. ...
https://en.wikipedia.org/wiki/Lipoatrophic_diabetes
*  Targets
Lipoatrophic Diabetes Mellitus. 1 , 5 Liver carcinoma. 1 , 217 Lung Neoplasms. 1 , 171 ...
https://pharos.nih.gov/idg/targets?facet=Grant+Application/5R01DC000353-29
*  Targets
Lipoatrophic Diabetes Mellitus. 1 , 5 Lipodystrophy. 1 , 32 Liver Cirrhosis. 1 , 101 ...
https://pharos.nih.gov/idg/targets?facet=Grant+Application/5R01HL036709-22&order=$antibodyCount
*  Cholesterol Metabolism and Lipid Transfer in Diabetes
Diabetes Mellitus, Lipoatrophic. A type of diabetes mellitus that is characterized by severe INSULIN RESISTANCE and ... Diabetes Mellitus, Type 1. A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the ... Diabetes Mellitus, Type 2. A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is ... The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million ...
https://www.bioportfolio.com/resources/trial/71022/Cholesterol-Metabolism-and-Lipid-Transfer-in-Diabetes.html
*  Syndromes of Extreme Insulin Resistance | Springer for Research & Development
Dysregulation of insulin-like growth factors in a case of generalized acquired lipoatrophic diabetes mellitus (Lawrence ... Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401: 73-76, 1999.PubMed ... Reitman ML, Gavrilova O. A-ZIP/F-1 mice lacking white fat: a model for understanding lipoatrophic diabetes. Int J Obes Relat ... Lipoatrophic diabetes and end-stage liver disease secondary to nonalcoholic steatohepatitis with recurrence after liver ...
https://rd.springer.com/chapter/10.1007/978-1-4757-6260-0_14
*  Index - Liposuction 101 Liposuction Training
Lipoatrophic diabetes mellitus, 58. Lipoatrophy, 57-60, 58, 59. Lipoblast, 218. Lipodystrophy, 57 ... Adult-onset, non-insulin-dependent diabetes mellitus, 54, 264, 305. Adult-onset insulin-dependent diabetes mellitus, 58 ...
http://liposuction101.com/liposuction-textbook/index/
*  Estrogen and Diabetes
... clinicaltrials.gov Diabetes has recently been referred to as ... Diabetes Mellitus, Lipoatrophic. A type of diabetes mellitus ... Diabetes Mellitus, Type 1. A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the ... Diabetes Mellitus, Type 2. A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is ... A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and ...
https://www.bioportfolio.com/resources/trial/200172/Estrogen-and-Diabetes.html
*  Safety and Efficacy of Exenatide as Monotherapy
Diabetes Mellitus, Lipoatrophic. A type of diabetes mellitus that is characterized by severe INSULIN RESISTANCE and ... Diabetes Mellitus, Type 1. A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the ... Diabetes Mellitus, Type 2. A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is ... A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and ...
https://www.bioportfolio.com/resources/trial/104643/Safety-and-Efficacy-of-Exenatide-as-Monotherapy.html
*  The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)
Diabetes Mellitus, Lipoatrophic. A type of diabetes mellitus that is characterized by severe INSULIN RESISTANCE and ... Diabetes Mellitus, Type 1. A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the ... Diabetes Mellitus, Type 2. A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is ... and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom ...
https://www.bioportfolio.com/resources/trial/65864/The-CANTATA-MSU-Trial-CANagliflozin-Treatment-And-Trial-Analysis-Metformin-and-SUlphonylurea.html
*  Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M)...
Diabetes Mellitus, Lipoatrophic. A type of diabetes mellitus that is characterized by severe INSULIN RESISTANCE and ... Diabetes Mellitus, Type 1. A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the ... Diabetes Mellitus, Type 2. A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is ... A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and ...
https://www.bioportfolio.com/resources/trial/70480/Evaluate-Efficacy-Safety-and-Tolerability-of-AZD1656-as-Add-on-Treatment-to.html
*  Obesity and Obesity-Initiated Metabolic Syndrome: Mechanistic Links to Chronic Kidney Disease | American Society of Nephrology
... glucose tolerance after effective lipid-lowering therapy with bezafibrate in a patient with lipoatrophic diabetes mellitus: A ... and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes55 :2502- 2509,2006. ... For patients with a BMI ≥35 kg/m2, the odds ratio (OR) for developing CKD was 2.2 for those without diabetes and 2.8 for those ... The OR was even higher at 17.7 for individuals with diabetes and a BMI ≥35 kg/m2. Speckman et al. (17) examined the ...
https://cjasn.asnjournals.org/content/2/3/550
*  A Study of Postprandial Hyperglycemia in Patients With Type 2 Diabetes
Diabetes Mellitus, Lipoatrophic. A type of diabetes mellitus that is characterized by severe INSULIN RESISTANCE and ... Diabetes Mellitus, Type 1. A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the ... Diabetes Mellitus, Type 2. A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is ... A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and ...
https://www.bioportfolio.com/resources/trial/62997/A-Study-of-Postprandial-Hyperglycemia-in-Patients-With-Type-2-Diabetes.html